Angel Yeast's Breakthrough in Yeast Protein Research: AngeoPro Shown to Promote Calcium Absorption, Aiding in Osteoporosis Prevention
Angel Yeast's Breakthrough in Yeast Protein Research: AngeoPro Shown to Promote Calcium Absorption, Aiding in Osteoporosis Prevention |
[22-September-2025] |
YICHANG, China, Sept. 23, 2025 /PRNewswire/ -- Angel Yeast (SH600298), a leading global food ingredients and biotechnology company, today announced a major advancement in research on its yeast protein product AngeoPro. New scientific studies confirm that yeast protein provides a balanced amino acid profile—nearly 48% of which are essential amino acids—closely aligning with the ideal protein reference standard. Importantly, the findings highlight yeast protein's ability to enhance calcium absorption and its potential role in supporting long-term bone health. Research Highlights: Calcium Absorption and Bone Strength This study, conducted in collaboration with Huazhong Agricultural University and published in Food Research International, evaluated how yeast protein impacts calcium metabolism and bone health in rat models maintained on both normal and calcium-deficient diets. Key findings include:
Shaping the Future of Bone Health with Yeast Protein While yeast protein has already shown significant potential in nutritional support for bone health, researchers believe this is only the beginning. Future studies will examine how yeast protein interacts with gut microbiota and will explore the molecular pathways and clinical outcomes behind its role in calcium absorption and bone synthesis. Angel Yeast remains dedicated to advancing yeast protein research and product development, creating healthy and great-tasting solutions for consumers worldwide. The company will also continue expanding yeast protein applications across the food and nutrition sector, supporting innovation and contributing to improved bone health and quality of life.
SOURCE Angel Yeast | ||
Company Codes: Shanghai:600298 |